Bausch Health Soars 14.62% on Icahn's 90M Share Stake

On April 22, 2025, Bausch Health's stock surged by 14.62% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Bausch Health recently filed a supplement to its proxy statement, disclosing that Carl Icahn and his affiliates have cash-settled equity swaps for approximately 90 million of its common shares. This revelation has sparked considerable interest in the company's stock, as Icahn's involvement is often seen as a vote of confidence in a company's future prospects.

The supplement to the proxy statement amends disclosures in the original April 2 proxy statement, providing additional details on Icahn's economic exposure to Bausch Health. This update has been made available on the SEDAR+ and EDGAR websites, ensuring transparency and accessibility for all stakeholders.

Investors are closely monitoring the situation, as Icahn's significant stake in the company could potentially influence its strategic direction and future performance. The market's positive reaction to this news suggests that investors are optimistic about the potential benefits of Icahn's involvement.